Log On America, Inc. v. Promethean Asset Management LLC

United States District Court for the Southern District of New York · Corporations

CorporationsSecurities fraudConvertible preferred stockShort sellingSections 10(b), 13(d), and 16(b)Rule 12(b)(6)Rule 9(b)PSLRA

Facts

LOA entered into transaction documents under which several defendants paid $15 million for Series A convertible preferred stock and warrants. The agreement expressly permitted short sales up to a specified limit tied to warrant shares and also stated that the buyers were acquiring the securities for investment only but were not required to hold them for any minimum period. The certificate of designations capped any holder's beneficial ownership after conversion at 4.99% of LOA's outstanding common stock, and separate letter agreements also limited some defendants from exceeding 10% ownership in a 60-day period. LOA alleged that defendants used the convertible securities to short LOA stock, depress its price, and later cover through conversion, while also claiming insider trading, undisclosed group ownership, breach of contract, fraud, and entitlement to declaratory relief and rescission.

Issue

Whether LOA's complaint adequately stated federal securities, fraud, contract, and equitable claims based on defendants' alleged short-selling and conversion strategy. More specifically, the court considered whether conduct expressly permitted by the transaction documents could support claims for misrepresentation, market manipulation, insider trading, Section 13(d) reporting violations, Section 16(b) short-swing profit liability, breach of contract, and related equitable relief.

Rule

To state a Section 10(b) misrepresentation claim, a plaintiff must plead that, in connection with the purchase or sale of securities, the defendant, acting with scienter, made a false representation or omitted material information and that the plaintiff's reliance caused injury. A market manipulation claim under Section 10(b) requires damages, causation through reliance on misrepresentations, omissions, or a fraudulent scheme, scienter, a connection with the purchase or sale of securities, and use of the mails or a national securities exchange; conclusory allegations are insufficient. Under Section 13(d), a plaintiff must show beneficial ownership exceeding 5%, and group allegations require facts showing defendants acted together toward a common objective regarding acquiring, holding, voting, or disposing of the issuer's securities; under Section 16(b), the plaintiff must allege a purchase and sale by a more-than-10% beneficial owner within six months. Under New York law, breach of contract requires an agreement, plaintiff's performance, defendant's breach, and damages, while a fraud claim alongside a contract requires a duty independent of the contract, a collateral misrepresentation, or special damages unrecoverable in contract.

🔒

See the holding & full analysis

Create a free KwikCourt account to unlock the rest of this brief — and practice the case.

The court's holding and reasoning
Doctrine tests, pitfalls & exam hypotheticals
10 practice questions + 4 AI-graded essays on this case

Free sample · practice this case

Test yourself

One of 10 multiple-choice questions for this case. Pick an answer to see why.

North Shore Data, a Delaware telecom company based in Boston, sold convertible preferred shares and warrants to Harbor Vale Capital under a purchase agreement. The agreement expressly allowed Harbor Vale to maintain a net short position up to the number of warrant shares it could acquire, and also stated that Harbor Vale was not required to hold the securities for any minimum period. After Harbor Vale shorted the issuer's common stock within that limit, North Shore sued for securities fraud, alleging Harbor Vale falsely represented it would be only a passive long-term investor.

Which is the strongest argument for dismissal of the issuer's Section 10(b) misrepresentation claim?

Explanation. The majority treated the transaction documents as controlling. Where the contract plainly authorizes short sales and disclaims any minimum holding period, an issuer cannot plausibly base a Section 10(b) misrepresentation theory on that same conduct. The authorization defeats falsity and also makes scienter, reliance, and causation difficult to plead. (Derived from Log On America, Inc. v. Promethean Asset Management LLC (n.d.).)